GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)

Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers

NCT05047692 ·Status: COMPLETED ·Phase: PHASE1

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

NCT05633446 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers

NCT04666012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

NCT05096832 ·Status: COMPLETED ·Phase: PHASE3

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

NCT04904471 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

NCT04646590 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults

NCT04591184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

NCT04922788 ·Status: COMPLETED ·Phase: PHASE3

Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)

NCT05175950 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

NCT04795414 ·Status: UNKNOWN

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

NCT04847102 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

NCT05636319 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

NCT04783311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

NCT04636333 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

NCT05007951 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals

NCT05305300 ·Status: COMPLETED ·Phase: PHASE1

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

NCT04550351 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

NCT05003479 ·Status: UNKNOWN ·Phase: PHASE1

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

NCT05599516 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

NCT03170609 ·Status: COMPLETED ·Phase: PHASE2

Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

NCT05050474 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

NCT05125874 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Anthrax Vaccine, GC1109

NCT01867957 ·Status: COMPLETED ·Phase: PHASE1

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

NCT04982068 ·Status: UNKNOWN ·Phase: PHASE1

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

NCT04911790 ·Status: COMPLETED ·Phase: PHASE4